Business Context and Reporting Period
Company: Standard BioTools Inc. (Nasdaq: LAB)
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2026
Reporting Period: Preliminary financial results for the three months and fiscal year ended December 31, 2025.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing preliminary financial results. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that these results are unaudited and based on current expectations.
Material Changes
The filing does not contain specific data regarding material changes versus prior comparable periods. It notes that the preliminary results may be adjusted following the completion of annual audit procedures and financial closing reviews.
Guidance, Outlook, and Risks
- Unaudited Status: The financial information is preliminary and unaudited.
- Adjustment Risk: Results may be adjusted due to the completion of annual audit procedures.
- Comprehensive Statement: This information does not represent a comprehensive statement of financial results for the period.
- Legal Disclaimer: The information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability and incorporation by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached press release) for specific revenue and profit figures, as they are not included in the 8-K text.
- Monitor for the release of the audited annual report (Form 10-K) to confirm final financial results.
- Verify if any adjustments to the preliminary numbers are announced following the completion of the annual audit.